Dosage and administration
Adults and children 12 years of age and older take 2 tablets every 4 to 6 hours as needed, do not exceed 8 tablets in 24 hours, or as directed by a doctor Children under 12 years of age: ask a doctor
Adults and children 12 years of age and older take 2 tablets every 4 to 6 hours as needed, do not exceed 8 tablets in 24 hours, or as directed by a doctor Children under 12 years of age: ask a doctor
do not use if packet is opened or torn store at room temperature, 59° - 86°F (15° - 30°C) avoid excessive heat and humidity
Drug Facts
Phenylephrine HCl 5 mg
nasal decongestant
temporarily relieves nasal congestion due to:
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping an MAOI drug. If you do not know if your prescription drug contains an MAOI, consult a doctor or pharmacist before taking this product.
When using this product do not exceed recommended dose
If pregnant or breast-feeding ask a health professional before use.
Keep out of reach of children In case of overdose, get medical help or contact a Poison Control Center right away.
croscarmellose sodium, D&C Red #27, dicalcium phosphate, magnesium stearate, microcrystalline cellulose, silicon dioxide, starch, stearic acid
1-866-651-3660 Monday-Friday
8:00am-5:00pm EST
Product #1262
Nasal & Sinus
Decongestant II
Nasal Decongestant
Active ingredient:
Phenylephrine
These quality comfort tablets are formulated and packaged for use in the
workplace and meet ANSI Z308.1-2015 standards. They are sealed in
tamper-evident packets for safety and convenience.
100 Tablets • 2 Tablets Per Packet

Product #1264
Nasal & Sinus
Decongestant II
Nasal Decongestant
Active ingredient:
Phenylephrine
These quality comfort tablets are formulated and packaged for use in the
workplace and meet ANSI Z308.1-2015 standards. They are sealed in
tamper-evident packets for safety and convenience.
250 Tablets • 2 Tablets Per Packet

| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e4e263da-1c53-440f-bb80-b7a575843b5a | Product name | 1 | 20260313 |
| d2168cac-a261-415a-9c78-3522859fa720 | Product name | 3 | 20251124 |
| 05a8cdd1-eeb8-409e-b938-0778225eca7d | Product name | 4 | 20250221 |
| e5b5c132-b15d-435b-9faa-2f74e5cadcf9 | Product name | 8 | 20250220 |
| f489e8f3-5c9e-4818-b539-a73587edcfc7 | Product name | 2 | 20240229 |
| 0f7ae452-206d-4fc4-868d-56fc47074084 | Product name | 1 | 20231011 |
| b5abe2e3-39a1-43eb-9bff-f3c1653fe3df | Product name | 2 | 20190930 |
| e0b6c8be-f2bd-9f86-a9fc-3ed56ffaa814 | Product name | 3 | 20150910 |
| 42f3c020-f1b3-89bc-7bdc-e1f10e680485 | Product name | 1 | 20140508 |
| e949165d-714d-e548-2b76-0cb5def16f30 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 73598-1262-1 | 2024-04-26 | C162847 | 48780-1 | 1030e365-1138-111a-e063-dadaa90a10e2 | NASAL AND SINUS DECONGESTANT II |
| 73598-1262-1 | 2024-04-26 | C162847 | 48780-1 | 1030e365-1138-111a-e063-dadaa90a10e2 | NASAL AND SINUS DECONGESTANT II |
| 73598-1264-1 | 2024-04-26 | C162847 | 48780-1 | 1030e365-1138-111a-e063-dadaa90a10e2 | NASAL AND SINUS DECONGESTANT II |
| 73598-1264-1 | 2024-04-26 | C162847 | 48780-1 | 1030e365-1138-111a-e063-dadaa90a10e2 | NASAL AND SINUS DECONGESTANT II |
| 73598-1262-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1138-111a-e063-dadaa90a10e2 | NASAL AND SINUS DECONGESTANT II |
| 73598-1262-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1138-111a-e063-dadaa90a10e2 | NASAL AND SINUS DECONGESTANT II |
| 73598-1264-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1138-111a-e063-dadaa90a10e2 | NASAL AND SINUS DECONGESTANT II |
| 73598-1264-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1138-111a-e063-dadaa90a10e2 | NASAL AND SINUS DECONGESTANT II |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73598-1262 | 73598-1262-1 |
| 73598-1264 | 73598-1264-1 |
Every source-derived ingredient row is available through these pages.
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 2 | 2024-04-26 | full-release | 2026-06-01 00:11:30 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NASAL and SINUS DECONGESTANT | PHENYLEPHRINE HYDROCHLORIDE | JHK Inc dba American Safety & First Aid | 63e51305-2575-49c4-9fda-7b3e1b4b6ede | 2026-10-26 | Warnings | 73598-1264-1 73598-1262-1 73598-1262 73598-1264 73598126201 73598126401 6c970760-6461-4580-8e7e-7c13c0ec9735 63e51305-2575-49c4-9fda-7b3e1b4b6ede |
Adverse event summaries are temporarily unavailable. Other product information remains available.